NEW YORK, April 7, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
World In Vitro Diagnostics Market
http://www.reportlinker.com/p0470752/World-In-Vitro-Diagnostics-Market.html
Global demand to increase 6.1% annually through 2014
The Freedonia Group projects world demand for in vitro
diagnostic (IVD) products increasing 6.1 percent annually to nearly
$68 billion in 2014. Based on the advanced nature of medical
delivery systems and widespread insurance coverage for primary
health care procedures, the developed countries combined will
absorb more than two-thirds of this total. Demand in the developing
countries as a whole will expand faster as medical delivery systems
are expanded and upgraded and the availability and accessibility of
basic health care services improve.
Nucleic acid testing to be fastest growing type
Clinical chemistry and immunoassay will remain the top two IVD
methodologies, the former based on sales of personal blood glucose
monitors and test strips and the latter due to the penetration of
high value-added chemiluminescent products into infectious disease
and drug testing markets. Nucleic acid testing products will post
the fastest growth in global demand gains among all IVD products
based on throughput, accuracy and speed advantages, especially in
the detection of infectious diseases and cancer markers. Because of
increasing blood glucose monitoring among diabetic patients,
endocrine condition testing will remain the largest IVD application
through 2014 and beyond. Due to their ability to quantify heart
attack and embolism risk prior to occurrence, hemostasis tests for
D-dim
‘/>”/>
